Trevena
TRVN
#10620
Rank
A$0.01 M
Marketcap
A$0.01580
Share price
0.00%
Change (1 day)
-99.42%
Change (1 year)

Earnings for Trevena (TRVN)

Earnings in 2024 (TTM): -A$46.06 Million

According to Trevena's latest financial reports the company's current earnings are A$0.54 Million. In 2023 the company made an earning of -A$52.17 Million, an increase over its 2022 earnings that were of -A$75.27 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Trevena from 2013 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$46.06 Million-11.7%
2023 -A$52.17 Million-30.69%
2022 -A$75.27 Million1.38%
2021 -A$74.25 Million78.04%
2020 -A$41.71 Million21.3%
2019 -A$34.38 Million-13.91%
2018 -A$39.94 Million-59.75%
2017 -A$99.21 Million-31.77%
2016 -A$0.15 Billion101.73%
2015 -A$72.08 Million1.14%
2014 -A$71.27 Million114.83%
2013 -A$33.18 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
A$11.83 B-26,645.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$33.15 B-74,449.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
-A$0.12 Billion 155.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-A$1.08 Billion 2,321.25%๐Ÿ‡บ๐Ÿ‡ธ USA
AcelRx Pharmaceuticals
ACRX
-A$14.78 Million-66.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Cara Therapeutics
CARA
-A$90.17 Million 102.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
-A$0.91 Billion 1,918.69%๐Ÿ‡บ๐Ÿ‡ธ USA